Article
[The clinical importance of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in the 5-fluoropyrimidine-based therapy of metastatic colorectal tumours].
Magyar onkologia - 1 Jan 2004
Budai Barna, Hitre Erika, Adleff Vilmos, Czeglédi Ferenc, Gyergyay Fruzsina, Láng István, Kralovánszky Judit
Abstract excerpt
The authors investigated the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in 101 metastatic colorectal cancer patients treated with 5-fluoropyrimidine-based therapy and in 196 healthy individuals by PCR-RFLP method. There was no significant difference in genotype distribution of patients and healthy controls, and between subgroups investigated according to clinical parameters (age, gender, tumor...
Topics
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Combined Chemotherapy Protocols
- Case-Control Studies
- Colorectal Neoplasms
- Cytosine
- Female
- Genotype
- Humans
